Abstract
Belatacept is an attractive option for immunosuppression after renal transplantation. Renal allograft function is superior when compared to calcineurin inhibitor (CNI) based therapy in "de novo" treated patients and it has also been proposed that individuals at high cardiovascular (CV) risk may benefit most. In this retrospective cohort study, we assessed the efficacy and safety of treating patients at high cardiovascular risk with Belatacept (n = 34, for 1194 observation months) when compared to a matched control group of 150 individuals under CNI immunosuppression (for 7309 months of observation). The estimated glomerular filtration rate (eGFR) increased for patients taking Belatacept but decreased during CNI-based therapy (+2.60 vs. -0.89 mL/min/1.73 m2/year, p = 0.006). In a multivariate Cox regression model, Belatacept remained the only significant factor associated with the improvement of eGFR (HR 4.35, 95%CI 2.39-7.93). Belatacept treatment was not a significant risk factor for renal allograft rejection or graft loss. In terms of safety, the only significant risk factor for de novo cardiovascular events was a pre-existing cerebrovascular disease, but Belatacept was not associated with a significant risk reduction. Belata...Continue Reading
References
Dec 21, 2007·The New England Journal of Medicine·Henrik EkbergUNKNOWN ELITE-Symphony Study
Mar 21, 2009·Transplantation·Robert LatekRobert Townsend
Apr 28, 2009·Transplantation·Giovanni StalloneLoreto Gesualdo
Apr 27, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·F VincentiC P Larsen
Apr 27, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A DurrbachJ Grinyó
Oct 27, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K E LambH-U Meier-Kriesche
Nov 6, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Lionel RostaingJosep Grinyó
Oct 14, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·F VincentiB Charpentier
Jul 24, 2012·Transplant International : Official Journal of the European Society for Organ Transplantation·Josep GrinyoNassim Kamar
Sep 21, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L RostaingC P Larsen
Feb 11, 2014·Transplantation Reviews·Karl Martin Wissing, Lissa Pipeleers
Jul 1, 2014·Clinical Transplantation·Felix S SeibertTimm H Westhoff
Nov 25, 2014·The Cochrane Database of Systematic Reviews·Philip MassonAngela C Webster
Jan 23, 2015·Nefrología : publicación oficial de la Sociedad Española Nefrologia·Edoardo MelilliJosep M Cruzado
May 20, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·G GuptaA L King
Jan 1, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Y Le MeurC Legendre
Jan 28, 2016·The New England Journal of Medicine·Flavio VincentiChristian P Larsen
Oct 28, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A DurrbachJ M Grinyó
Oct 30, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S FlormanC P Larsen
Nov 28, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Josep M GrinyóNassim Kamar
Jul 15, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D BertrandD Guerrot
Jul 11, 2018·Clinical Kidney Journal·Edoardo MelilliJosep Cruzado